Acute erythroleukemia in a rheumatoid arthritis patient during low-dose methotrexate therapy

被引：7
|
作者：
Choi, BR
Ahn, MJ
Lee, W
Kim, TH
Bae, SC
Jun, JB
机构：
[1] Hanyang Univ, Hosp Rheumat Dis, Seoul 133792, South Korea
[2] Hanyang Univ, Coll Med, Dept Internal Med, Seoul 133792, South Korea
[3] Hanyang Univ, Coll Med, Dept Lab Med, Seoul 133792, South Korea
来源：
RHEUMATOLOGY INTERNATIONAL | 2005年 / 25卷 / 04期
关键词：
acute erythroleukemia; low-dose methotrexate; rheumatoid arthritis;
D O I：
10.1007/s00296-004-0502-9
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
Acute leukemia is uncommonly seen with rheumatoid arthritis during or following treatment with low-dose methotrexate, a safe and effective treatment for the arthritic condition. We describe here a 68-year-old woman with rheumatoid arthritis who developed acute erythroleukemia during low-dose methotrexate therapy (total dose 1702.5 mg). This may be the first such case reported in the literature.
引用
收藏
页码：311 / 313
页数：3
相关论文
共 50 条
  • [41] Polymorphisms in the thymidylate synthase and methylenetetrahydrofolate reductase genes and sensitivity to the low-dose methotrexate therapy in patients with rheumatoid arthritis
    Kumagai, K
    Hiyama, K
    Oyama, T
    Maeda, H
    Kohno, N
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2003, 11 (05) : 593 - 600
  • [42] The effect of low-dose methotrexate on bone mineral density in patients with early rheumatoid arthritis
    Tascioglu, F
    Oner, C
    Armagan, O
    RHEUMATOLOGY INTERNATIONAL, 2003, 23 (05) : 231 - 235
  • [43] Three decades of low-dose methotrexate in rheumatoid arthritis: Can we predict toxicity?
    Romao, Vasco C.
    Lima, Aurea
    Bernardes, Miguel
    Canhao, Helena
    Fonseca, Joao Eurico
    IMMUNOLOGIC RESEARCH, 2014, 60 (2-3) : 289 - 310
  • [44] Benefits and risks of low-dose glucocorticoid treatment in the patient with rheumatoid arthritis
    Kavanaugh, Arthur
    Wells, Alvin F.
    RHEUMATOLOGY, 2014, 53 (10) : 1742 - 1751
  • [45] LACK OF IMMUNOSUPPRESSIVE EFFECT OF LOW-DOSE ORAL METHOTREXATE ON LYMPHOCYTES IN RHEUMATOID-ARTHRITIS
    MARTINEZOSUNA, P
    ZWOLINSKA, JB
    SIKES, DH
    CORY, JG
    SILVEIRA, LH
    JARA, LJ
    ESPINOZA, LR
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 1993, 11 (03) : 249 - 253
  • [46] Is Pharmacogenetic Panel Testing Applicable to Low-Dose Methotrexate in Rheumatoid Arthritis? - A Case Report
    Jeiziner, Chiara
    Allemann, Samuel S.
    Hersberger, Kurt E.
    Schwabedissen, Henriette E. Meyer zu
    PHARMACOGENOMICS & PERSONALIZED MEDICINE, 2022, 15 : 465 - 475
  • [47] Three decades of low-dose methotrexate in rheumatoid arthritis: Can we predict toxicity?
    Vasco C. Romão
    Aurea Lima
    Miguel Bernardes
    Helena Canhão
    João Eurico Fonseca
    Immunologic Research, 2014, 60 : 289 - 310
  • [48] The effect of low-dose methotrexate on bone mineral density in patients with early rheumatoid arthritis
    Funda Tascioglu
    Cengiz Oner
    Onur Armagan
    Rheumatology International, 2003, 23 : 231 - 235
  • [49] Determination of erythrocyte methotrexate polyglutamates by liquid chromatography/tandem mass spectrometry after low-dose methotrexate therapy in Chinese patients with rheumatoid arthritis
    Mo, Xiaolan
    Wen, Yuguan
    Ren, Bin
    Chen, Jie
    Xu, Chenshu
    Wang, Xueding
    Huang, Min
    Chen, Xiao
    JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2012, 907 : 41 - 48
  • [50] Hepatic and hematological adverse effects of long-term low-dose methotrexate therapy in rheumatoid arthritis: An observational study
    Dubey, Lily
    Chatterjee, Suparna
    Ghosh, Alakendu
    INDIAN JOURNAL OF PHARMACOLOGY, 2016, 48 (05) : 591 - 594
12345